567PResults of a phase I study of andecaliximab in combination with mFOLFOX6 and bevacizumab in patients with previously untreated metastatic colorectal cancer. (23rd October 2018) - Lenz, H-J; Park, H; Shah, M A; Berlin, J D; Bruetman, D; Chaves, J; Gordon, M; Patel, R; Starodub, A; Liu, J; Baker Brachmann, C; Bhargava, P; et al.